Application no. and date | 21715035.8 (espacenet) (Federated) (European Patent Register), 20210305 | Patent/reg. no. and date | DK/EP 4114390, 20241204 | Publication date | 20230111 | Priority no. and date | US 202062986297 P, 20200306 | EP pub. no. and date |
EP 4114390 20230111 | Effective date | | Applicant/owner | Amicus Therapeutics, Inc., 3675 Market Street
Philadelphia, PA 19104, US | Applicant ref. no. | 2004100 | Inventor | BENJAMIN, Elfrida, AMICUS THERAPEUTICS, INC. 3675 Market Street
Philadelpha, Pennsylvania 19104, US, WU, Xiaoyang, AMICUS THERAPEUTICS, INC. 3675 Market Street
Philadelpha, Pennsylvania 19104, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/445 (2006.01) , A61P 3/00 (2006.01) | Title | FREMGANGSMÅDER TIL BEHANDLING AF FABRYS SYGDOM HOS PATIENTER MED EN MUTATION I GLA-GENET | Int. application no. | US2021020984 | Int. publication no. | WO2021178737 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|